The FDA is warning the public that treatment with chronic, high doses of Diflucan (fluconazole) during the first trimester of pregnancy may be associated with a rare and distinct set of birth defects in infants. Diflucan is prescribed for fungal infections and infections arising out of chemotherapy or radiation therapy.